This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Japan's Suntory to buy Daiichi Sankyo OTC unit in $1.55 billion deal

( April 16, 2026, 00:14 GMT | Official Statement) -- MLex Summary: Japanese beverage maker Suntory Holdings said Wednesday it will acquire all shares of Daiichi Sankyo Healthcare from its parent Daiichi Sankyo for 246.5 billion yen ($1.55 billion), as it looks to expand in self-medication and self-care. The Osaka-based beverage group plans a three-stage purchase of the over-the-counter drugmaker, beginning with a 30 percent stake on June 1 and culminating in full ownership by June 1, 2029, it said. The timeline may change depending on competition law reviews and other regulatory procedures, the company added.The statement is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections